News

Two Harvard Stem Cell Institute (HSCI) researchers — a stem cell biologist and a practicing cardiologist at Brigham and Women’s Hospital — have identified a protein in the blood of mice and humans that may prove to be the first effective treatment for the...

Using a difficult laboratory technique, HSCI physician-researchers have isolated genetically healthy stem cells from patients with Pearson Marrow Pancreas Syndrome (PS), a generally fatal infant blood disorder with less than a hundred reported cases...

The NHLBI Progenitor Cell Biology Consortium (PCBC) is soliciting applications for Pilot Studies. NHLBI makes funds available for PCBC pilot studies to foster innovative, high-risk approaches with a potential for unusually high impact to advance the...

Harvard Stem Cell Institute (HSCI) Co-director Douglas Melton, PhD, and Evotec AG have entered into their second research collaboration to find biological pathways and signals that could be therapeutically relevant to diabetic patients. The objective of...

Human Pluripotent Stem Cell Culture: Feeder versus Feeder-free Two-Day Training Workshop by the HSCI iPS Core Facility When: Monday, December 9, 2013, 1:30 PM-6:00 PM and Tuesday, December 10, 2013, 1:30 PM - 6:00 PM Where: Harvard University, Bauer...

The New York Stem Cell Foundation (NYSCF) announced today that Amy Wagers, PhD, Professor at Harvard University, will be the 2013 recipient of the NYSCF – Robertson Stem Cell Prize, which has been awarded since 2011 for extraordinary achievements in...